These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 15064939
1. Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Van Dyck M, Proesmans W. Pediatr Nephrol; 2004 Jun; 19(6):688-90. PubMed ID: 15064939 [Abstract] [Full Text] [Related]
2. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome. Caletti MG, Balestracci A, Missoni M, Vezzani C. Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713 [Abstract] [Full Text] [Related]
3. Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. Trachtman H, Gauthier B. J Pediatr; 1988 Feb; 112(2):295-8. PubMed ID: 2828592 [No Abstract] [Full Text] [Related]
4. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria]. Camacho Díaz JA, Giménez Llort A, García García L, Jiménez González R. An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896 [Abstract] [Full Text] [Related]
5. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function]. Osterziel KJ, Nagel F, Dietz R. Z Kardiol; 1994 Sep; 83 Suppl 4():81-7. PubMed ID: 7856286 [Abstract] [Full Text] [Related]
6. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria. Székács B, Vajo Z, Dachman W. Acta Physiol Hung; 1996 Sep; 84(4):361-7. PubMed ID: 9328608 [Abstract] [Full Text] [Related]
7. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease. Nakamura T, Fujiwara N, Kawagoe Y, Sugaya T, Ueda Y, Koide H. Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070 [Abstract] [Full Text] [Related]
8. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome. Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C. Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876 [Abstract] [Full Text] [Related]
9. Renal effects of angiotensin converting enzyme inhibitors in hypertension. Bauer JH, Reams GP. Am J Med; 1986 Oct 31; 81(4C):19-27. PubMed ID: 3022581 [Abstract] [Full Text] [Related]
10. Impact of enalapril on renal function in patients with severe chronic kidney disease. Vernaglione L. Nephrol Dial Transplant; 2007 Feb 31; 22(2):665-6. PubMed ID: 16951420 [No Abstract] [Full Text] [Related]
11. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF. JAMA; 2003 Sep 10; 290(10):1360-70. PubMed ID: 12966129 [Abstract] [Full Text] [Related]
12. Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center. Oh G, Lau KK. Int Urol Nephrol; 2012 Oct 10; 44(5):1467-72. PubMed ID: 22116676 [Abstract] [Full Text] [Related]
13. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J, Diabetics Exposed to Telmisartan and Enalapril Study Group. N Engl J Med; 2004 Nov 04; 351(19):1952-61. PubMed ID: 15516696 [Abstract] [Full Text] [Related]
14. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor. Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, Usui K, Nagashima M. Clin Nephrol; 2002 Aug 04; 58(2):95-102. PubMed ID: 12227694 [Abstract] [Full Text] [Related]
15. Losartan and enalapril are comparable in reducing proteinuria in children. Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C. Kidney Int; 2012 Oct 04; 82(7):819-26. PubMed ID: 22739977 [Abstract] [Full Text] [Related]
16. Strict blood-pressure control and progression of renal failure in children. ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F. N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849 [Abstract] [Full Text] [Related]
17. Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy. Caletti MG, Missoni M, Vezzani C, Grignoli M, Piantanida JJ, Repetto HA, Exeni R, Rasse SM. Pediatr Nephrol; 2011 Aug 22; 26(8):1247-54. PubMed ID: 21533629 [Abstract] [Full Text] [Related]
18. Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Rodicio JL, Alcazar JM, Ruilope LM. Kidney Int; 1990 Oct 22; 38(4):590-4. PubMed ID: 2232500 [No Abstract] [Full Text] [Related]
19. Long-term therapy with enalapril in patients with nephrotic-range proteinuria. Proesmans W, Wambeke IV, Dyck MV. Pediatr Nephrol; 1996 Oct 22; 10(5):587-9. PubMed ID: 8897561 [Abstract] [Full Text] [Related]
20. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group. Clin Ther; 2008 Mar 22; 30(3):482-98. PubMed ID: 18405787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]